Skip to main content

Table 3 Process Outcomes at baseline and three months

From: The effects of an innovative GP-physiotherapist partnership in improving COPD management in primary care

 

Baseline

Three Months

P-value

Current smokers

5 (16%)

1 (3%)

0.13

Vaccinated for influenza

27 (87%)

28 (90%)

1.00

Vaccinated for pneumococcus

18 (58%)

23 (74%)

0.06

Inhaler technique reviewed

Not assessed

26/26a(100%)

N/A

GPMP and/or action plan initiated

4b(13%)

22 (71%)

N/A

Reported exacerbations

0 (0%)

1 (3%)

1.00

ED admissions for:

 COPD

0 (0%)

1 (3%)

N/A

 Heart disease

0 (0%)

1 (3%)

 

 Other

3 (10%)

4 (13%)

 
  1. Data presented as Number (%)
  2. Abbreviations: COPD chronic obstructive pulmonary disease, ED emergency department, GPMP general practitioner management plan, N/A not applicable
  3. an = 26 had prescribed inhalers for COPD management
  4. b4/31 participants with previous doctor diagnosis of COPD with self-reported GPMP and/or action plan